Patient and physician preferences for treatment of hepatitis C virus infection in Japan: a discrete choice experiment
This study highlights the importance of patient-centered care in HCV treatment and the need to raise awareness of the public subsidy for hepatitis, and to ensure an effective access scheme for the patients. Simplifying regimens like once-daily pills and minimal monitoring may enhance treatment convenience. Improved patient-physician communication supports optimized strategies, aiding Japan's goal of HCV elimination by 2030.
Authors
- Yi Piao (ORCID: https://orcid.org/0009-0008-3162-543X)
- Jamie Zagorski (ORCID: https://orcid.org/0009-0007-9633-6682)
- Yuichiro Eguchi (ORCID: https://orcid.org/0000-0003-4693-5736)
- Daisuke Nakamoto
- Masahisa Jinushi
- Michael LoPresti (ORCID: https://orcid.org/0000-0002-2389-8218)
- Hajime Mizutani
- Kyung min Kwon
- Dilip Makhija
- Yunosuke Chikamura
Institutions
- Forage Genetics International (US)
- Gilead Sciences (United States) (US)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-03-25
- DOI
- https://doi.org/10.1080/13696998.2025.2483572
- Citations
- 1
- Primary Topic
- Pharmacy and Medical Practices
- Type
- article
- Field-Weighted Citation Impact
- 1.56